CD8A and neoplasm: Furthermore, translational analyses from VOLTAGE-A showed that patients with positive PD-L1 assessed according to tumor proportion score, higher CD8+/regulatory T-cell ratio (≥2.5 versus <2.5), and higher tumor mutational burden (1.45 versus 0.84 mutations/Mbp) were more likely to experience a pCR [29].